PAPER Zhang Y, Zhang X, Zhou J, Li Y, Kai T, Zhang L
SEARCH RESULTS
347558 RESULTS
PAPER Wu K, Wang H, Feng F, Liu T, Sun Y
Multi-knowledge informed deep learning model for multi-point prediction of Alzheimer's disease progression.
Neural Netw. 2025 May;185:107203. Epub 2025 Feb 1 PubMed.PAPER Kobayashi K, Taniguchi C, Tanaka M, Kimura R, Komurasaki K, Kuwano M, Ikemoto M, Kawakami N, Oishi S, Hattori Y, Akaji K
Development of novel BACE1 inhibitors with a hydroxyproline-derived N-amidinopyrrolidine scaffold.
Bioorg Med Chem. 2025 Jan 28;120:118086. Epub 2025 Jan 28 PubMed.PAPER Xue H, Wang X, Jiang Q, Ma J, Wong MS
Peroxynitrite and amyloid-β dual-activated near-infrared theranostic probe for oxidative stress monitoring in Alzheimer's disease.
Biosens Bioelectron. 2025 May 1;275:117201. Epub 2025 Jan 28 PubMed.PAPER Rossi S, Milani M, Della Valle I, Apolloni S
Transcriptomic profiling of symptomatic and end-stage SOD1-G93A transgenic mice reveals extracellular matrix components as key players in ALS pathogenesis.
Biochim Biophys Acta Mol Basis Dis. 2025 Feb 6;1871(4):167707. Epub 2025 Feb 6 PubMed.PAPER Dahiya M, Kumar A, Yadav M, Chauhan S
β-pinene ameliorates ICV-STZ induced Alzheimer's pathology via antioxidant, anticholinesterase, and mitochondrial protective effects: In-silico and in-vivo studies.
Eur J Pharmacol. 2025 Mar 15;991:177307. Epub 2025 Jan 25 PubMed.PAPER Dhapola R, Kumari S, Sharma P, Vellingiri B, HariKrishnaReddy D
Advancements in autophagy perturbations in Alzheimer's disease: Molecular aspects and therapeutics.
Brain Res. 2025 Mar 15;1851:149494. Epub 2025 Feb 6 PubMed.PAPER Ahmad W, Shabbiri K
Glucose enrichment reduces lifespan and promotes tau phosphorylation in human tau-expressing C. elegans, unaffected by O-β-GlcNAcylation induction.
J Mol Med (Berl). 2025 Mar;103(3):327-338. Epub 2025 Feb 10 PubMed.PAPER Soni R, Shah J
Unveiling the significance of synaptic proteins in parkinson's pathogenesis: A review.
Int J Biol Macromol. 2025 Feb 7;:140789. Epub 2025 Feb 7 PubMed.PAPER Johnson TP, Tsoy E, Shen J, Rivera W, Lieu K, Salazar C, Tse M, Li Y, Goldberger L, Soo BM, Kramer J, Rosen HJ, Miller BL, Sirkis DW, Bonham LW, Yokoyama JS, Alzheimer’s Disease Neuroimaging Initiative
Reduced levels of angiogenesis biomarkers predict increased symptom severity in Chinese Americans with Alzheimer's disease with demographic-specific effect.
Neurocase. 2025 Feb 9;:1-10. Epub 2025 Feb 9 PubMed.PAPER Gu L, Zhang P, Zuo W, Shu H, Wang P
Correlation between plasma epidermal growth factor and follow-up cognitive decline in Parkinson's disease.
Neurol Sci. 2025 Feb 10; Epub 2025 Feb 10 PubMed.PAPER Zhang H, Bi F, Zhao P, Cui H, Tao X, Zhang J, Li C, Cao Y, Wang N, Li H
Longan Aril polysaccharides ameliorate cognitive impairment in AD mice via restoration of the immune phagocytosis of microglia.
J Ethnopharmacol. 2025 Mar 13;343:119464. Epub 2025 Feb 7 PubMed.PAPER Xiao X, Liu H, Yao R, Li Y, Liao X, Liu Y, Zhou Y, Wang J, Tang B, Jiao B, Li J, Shen L, Luo S
LMTK2 and CRB1 are two novel risk genes for Alzheimer's disease in Han Chinese.
J Prev Alzheimers Dis. 2025 Feb 7;:100087. Epub 2025 Feb 7 PubMed.PAPER Park JI, Lee S, Huber B, Devanand DP, Kim H, Goldberg TE, Alzheimer’s Disease Neuroimaging Initiative
Empirical classification of neuropsychiatric symptoms and association of classes with diagnostic progression and cognitive decline in MCI and AD populations.
Biol Psychiatry. 2025 Feb 6; Epub 2025 Feb 6 PubMed.PAPER Nasrolahzadeh M, Mohammadpoory Z, Haddadnia J
Small-world networks propensity in spontaneous speech signals of Alzheimer's disease: visibility graph analysis.
Sci Rep. 2025 Feb 10;15(1):4860. PubMed.Current Filters
- Date Range : All x